Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pico-Salax timing for colonoscopy bowel cleansing
NCT00885274Phase 4
Key facts
- Status
- Completed
- Start
- Nov 2008
- Primary completion
- Mar 2011
- Countries
- 1
- Sponsor
- Queen's University
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, single-blind trial of sodium picosulfate + magnesium oxide + citric acid, sponsored by Queen's University. Primary endpoint: Ottawa Bowel Preparation Scale. Started Nov 2008; status: completed.
02
Design
- Study design
- RandomizedSingle-blind
03
Who it enrols
Patients requiring colonoscopy, excluding those with significant comorbidities like heart or renal failure, or previous intestinal surgery.
04
Endpoints
Primary
Ottawa Bowel Preparation Scale
Secondary
Patient tolerance of preparation
Beyond the preview
Go deeper on NCT00885274.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885274.